GlassScriptPhysician profile
Rhett B Lakin
NPI 1639345242
$6,860.26
in general payments reported to CMS, 2019-2025
10 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.23 · 2020: $815 · 2021: $1,333 · 2022: $3,958 · 2023: $240 · 2024: $228 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $4,436.85 | 2020-2024 | |
| Arthrex, INC. | $1,455.68 | 2022 | |
| Treace Medical Concepts, INC. | $227.88 | 2025 | |
| Depuy Synthes Sales INC. | $196.69 | 2023-2024 | Motoband |
| Medtronic, INC. | $156.07 | 2023-2024 | Intellis Adaptivestim |
| Stryker Corporation | $143.38 | 2021-2024 | Citrefix, N/A, Na |
| Organogenesis INC. | $112.98 | 2021-2025 | Affinity |
| Acera Surgical, INC. | $95.50 | 2022-2023 | Restrata Wound Matrix |
| Wright Medical Technology, INC. | $35.23 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$377,538.49 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rhett Lakin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.